Efficient Neuronal Gene Transfer with AAV8 Leads to Neurotoxic Levels of Tau or Green Fluorescent Proteins
Open accessAbstract
Adeno-associated virus (AAV) serotype 8 appears to be the strongest of the natural serotypes reported to date for gene transfer in liver and muscle. In this study, we evaluated AAV8 in the brain by several methods, including biophotonic imaging of green fluorescent protein (GFP). In the adult rat hippocampus, levels of GFP expressed were clearly greater with AAV8 than with AAV2 or AAV5 by Western blot and biophotonic imaging and slightly but significantly greater than AAV1 by Western blot. In the substantia nigra, the GFP expression conferred by AAV8 was toxic to dopamine neurons, although toxicity could be avoided with dose titration. At the low dose at which there was no GFP toxicity from the GFP vector, another AAV8 vector for a disease-related (P301L) form of the microtubule-associated protein tau caused a 78% loss of dopamine neurons and significant amphetamine-stimulated rotational behavior. The AAV8 tau vector-induced cell loss was greater than that from AAV2 or AAV5 tau vectors, demonstrating that the increased gene transfer was functional. While the toxicity observed with GFP expression warrants great caution, the efficient AAV8 is promising for animal models of neurodegenerative diseases and potentially as well for gene therapy of brain diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AAV9 can cross the blood-brain barrier and transduce both neurons and astrocytes after intravenous administration.
“AAV9 can cross the blood–brain barrier and transduce both neurons and astrocytes after intravenous administration.7,10–11”
From Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism (2016) · cites this paper as [10]
AAV8 and AAV5 transduce a significantly greater area of the CNS in comparison with AAV2.
“AAV8 and AAV5 transduce a significantly greater area of the CNS in comparison with AAV2”
From Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism (2016) · cites this paper as [10]
Substantial neuronal tropism appears to be a central feature across widely diverse AAV capsid structures.
“Clearly, substantial neuronal tropism appears to be a central feature across widely diverse AAV capsid structures.”
From Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism (2016) · cites this paper as [10]
The citation lists haven’t been fetched yet
References 35 · Cited by 200
- Authors
- Klein, R. L., Dayton, R. D., Leidenheimer, N. J., Jansen, K., Golde, T. E., & Zweig, R. M.
- Affiliations
- Louisiana State University Health Sciences Center Shreveport (US)
- Mayo Clinic (US)
- Corresponding author
- Klein, Ronald L.
- Venue
- Molecular Therapy
- Publisher
- Elsevier BV
- Published
- 2006-03
- Volume
- 13
- Issue
- 3
- Pages
- 517-527
- ISSN
- 1525-0016 (ISSN-L)
- PMC
- PMC2987642
- OpenAlex
- W1987114379
- Cited by
- 200
- References
- 35
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 4 · 2023: 10 · 2022: 8 · 2021: 4 · 2020: 9 · 2019: 10 · 2018: 12 · 2017: 15 · 2016: 10 · 2015: 12 · 2014: 8 · 2013: 8 · 2012: 13
- FWCI
- 5.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Therapy (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS048450)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- AAV8, adeno-associated virus serotypes, gene delivery to the brain, P301L tau, tauopathy, AAV2, AAV5, AAV1, hippocampus, substantia nigra, neurodegenerative disease models, gene therapy, dose titration, rotational behavior
- MeSH terms
- Dependovirus, Animals, Animals, Newborn, Cell Line, Cells, Cultured, Disease Models, Animal, Genetic Vectors, Hippocampus, Humans, Male, Neurons, Serotyping, Substantia Nigra, tau Proteins, Rats, Sprague-Dawley, Gene Transfer Techniques, Green Fluorescent Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review